Insider holders · CIK 0001348362
Lexaria Bioscience Corp. · LXRP
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Christopher BunkaCEO | 7,093,804 | 6,081,844 | 13,175,648 | Sep 4, 2018 · 4:56 pm EDT | Form 4 |
| John Martin DochertyPresident | — | 1,585,750 | 1,585,750 | Sep 4, 2018 · 4:16 pm EDT | Form 4 |
| William Edward McKechnieDirector | 335,738 | — | 335,738 | May 31, 2018 · 4:00 pm EDT | Form 4 |
| Nicholas W BaxterDirector | 200,000 | — | 200,000 | Dec 17, 2015 · 2:59 pm EST | Form 4 |
| Baljinder Bhullarrelationship not stated | 155,375 | — | 155,375 | Apr 29, 2016 · 10:04 am EDT | Form 4 |
| Allan Horst SpissingerChief Financial Officer | 69,166 | — | 69,166 | Feb 15, 2019 · 2:06 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.